These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4582923)

  • 1. Ototoxicity: a clinical review.
    Ballantyne J
    Audiology; 1973; 12(5):325-36. PubMed ID: 4582923
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced deafness and its treatment.
    Ajodhia JM; Dix MR
    Practitioner; 1976 May; 216(1295):561-70. PubMed ID: 951390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hearing disorder in chronic renal insufficiency].
    Pluzhnikov MS; Kozhevnikova AP; Bondarenko BB
    Vestn Otorinolaringol; 1977; (1):95-9. PubMed ID: 322379
    [No Abstract]   [Full Text] [Related]  

  • 4. Recognizing and avoiding ototoxicity.
    Aagaard GN
    Postgrad Med; 1972 Oct; 52(4):141-5. PubMed ID: 4538456
    [No Abstract]   [Full Text] [Related]  

  • 5. Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uremia.
    Mathog RH; Klein WJ
    N Engl J Med; 1969 May; 280(22):1223-4. PubMed ID: 5767464
    [No Abstract]   [Full Text] [Related]  

  • 6. Ototoxicity induced by furosemide.
    Schwartz GH; David DS; Riggio RR; Stenzel KH; Rubin AL
    N Engl J Med; 1970 Jun; 282(25):1413-4. PubMed ID: 5445527
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ototoxicity of some drug agents].
    Iaroshevich VI
    Voen Med Zh; 1975 Oct; (10):31-4. PubMed ID: 54985
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ethacrynic acid and hearing disorders].
    Barillon A; Felix J
    Presse Med (1893); 1970 Nov; 78(51):2283. PubMed ID: 5496183
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ototoxicity of drugs].
    Fossati C
    Clin Ter; 1986 Jul; 118(2):137-43. PubMed ID: 2874911
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethacrynic acid: its usefulness and untoward effects.
    Schwartz FD; Pillay VK; Kark RM
    Am Heart J; 1970 Mar; 79(3):427-8. PubMed ID: 5308658
    [No Abstract]   [Full Text] [Related]  

  • 11. The cochleovestibular system/ototoxicity/clinical issues.
    Shulman A
    Ann N Y Acad Sci; 1999 Nov; 884():433-6. PubMed ID: 10842612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity.
    Tange RA
    Adverse Drug React Toxicol Rev; 1998; 17(2-3):75-89. PubMed ID: 9838967
    [No Abstract]   [Full Text] [Related]  

  • 13. Ototoxic therapeutic agents.
    Gnanapragasam A
    Med J Malaysia; 1975 Jun; 29(4):280-92. PubMed ID: 53779
    [No Abstract]   [Full Text] [Related]  

  • 14. Deafness. Review of intravenous ethacrynic acid.
    Beauchamp GD; Crouch TC
    J Kans Med Soc; 1975 Jul; 76(7):166-8, 180. PubMed ID: 1159337
    [No Abstract]   [Full Text] [Related]  

  • 15. Ototoxicity of ethacrynic acid. Demonstrated in a human temporal bone.
    Matz GJ; Beal DD; Krames L
    Arch Otolaryngol; 1969 Aug; 90(2):152-5. PubMed ID: 5794874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vertigo as a complication of drug therapy].
    Tokola RA
    Duodecim; 1986; 102(22):1732-8. PubMed ID: 3803261
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of hearing and ototoxicity.
    Brown RD; Feldman AM
    Annu Rev Pharmacol Toxicol; 1978; 18():233-52. PubMed ID: 348060
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of furosemide ototoxicity.
    Rybak LP
    J Otolaryngol; 1982 Apr; 11(2):127-33. PubMed ID: 7042998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretics and ototoxicity.
    David DS; Hitzig P
    N Engl J Med; 1971 Jun; 284(23):1328-9. PubMed ID: 5576449
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a new antituberculous agent. Capreomycin sulfate (capastat sulfate).
    JAMA; 1973 Jan; 223(2):179-80. PubMed ID: 4120232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.